Comparative study of anticoagulation versus saline flushes in continuous renal replacement therapy

Area of Science:

• Nephrology
• Critical Care Medicine
• Biomedical Engineering

Background:

• Systemic heparinization in continuous renal replacement therapy (CRRT) increases bleeding risk.
• Maintaining extracorporeal circuit patency is crucial for effective CRRT.
• Alternative anticoagulation strategies are needed to mitigate bleeding complications.

Purpose of the Study:

• To compare the efficacy of frequent saline flushes versus heparin anticoagulation for maintaining filter life during CRRT.
• To assess the impact of these strategies on bleeding episodes and patient outcomes.

Main Methods:

• A comparative study of 65 critically ill patients with acute renal failure undergoing CRRT (Continuous venovenous hemodialfiltration).
• One group received unfractionated heparin targeting aPTT of 45-55 seconds.
• The other group, with baseline aPTT > 55 seconds, used frequent saline flushes (30-min intervals) without anticoagulation.

Main Results:

• Average filter life was comparable between the heparin group (26 ± 6.4 hours) and the heparin-free saline flush group (24.5 ± 6.36 hours).
• The heparin-free group experienced significantly fewer bleeding episodes (0.13/patient) compared to the heparin group (0.45/patient).
• Mortality rates were similar between the groups (71% vs. 67%).

Conclusions:

• Frequent saline flushes are an effective strategy for maintaining extracorporeal circuits in CRRT, particularly in patients with elevated aPTT.
• This heparin-free approach significantly reduces bleeding complications without compromising filter lifespan.
• Saline flushes represent a safer alternative to heparin anticoagulation in specific CRRT patient populations.